Same price per vial — no bulk discount, just add more to one order.
20% off included — code WELCOME20 is reflected in this price and applied automatically at checkout.
For laboratory research use only · Not for human consumption · Read handling terms →
Third-party HPLC, mass-spec, and endotoxin testing on every batch — with the Certificate of Analysis included, not on request.
PT-141, also known as bremelanotide, is a melanocortin-receptor agonist derived from Melanotan II. It is investigated in research examining central nervous-system signaling pathways, with a focus on melanocortin-mediated activity in the brain.
Developed by Palatin Technologies following observations made during Melanotan II research, PT-141 differs from its predecessor by carrying a carboxyl group in place of an amide. It was investigated through clinical programs centered on melanocortin-mediated arousal signaling, positioning it as a more targeted successor within the melanocortin class.
PT-141 has been examined in receptor-pharmacology and behavioral models for MC3R and MC4R agonism and central melanocortin-pathway signaling. Compared with its structural parent, PT-141 shifts the research focus toward central melanocortin signaling rather than pigmentation, which is what distinguishes its profile. Its narrower receptor emphasis makes it a useful tool for studying MC3R and MC4R activity in the central nervous system.
Same-day dispatch before 2:00 PM CST, Monday through Saturday. Store lyophilized vials at −20°C, protected from light; reconstituted solutions at 2–8°C. Discreet, temperature-safe packaging. Guaranteed delivery with free reshipment.
Most researchers don’t ask. The ones who do, switch.
Reach out and get a response within minutes.